MUTATION OF THE SERINE 15 PHOSPHORYLATION SITE OF HUMAN P53 REDUCES THE ABILITY OF P53 TO INHIBIT CELL-CYCLE PROGRESSION

被引:0
作者
FISCELLA, M
ULLRICH, SJ
ZAMBRANO, N
SHIELDS, MT
LIN, D
LEESMILLER, SP
ANDERSON, CW
MERCER, WE
APPELLA, E
机构
[1] NIH,CELL BIOL LAB,BETHESDA,MD 20892
[2] THOMAS JEFFERSON UNIV,JEFFERSON CANC INST,PHILADELPHIA,PA 19107
[3] BROOKHAVEN NATL LAB,DEPT BIOL,UPTON,NY 11973
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Overexpression of wild-type p53 prevents cells from entering the S phase of the cell cycle. The amino-terminal transactivation region of p53 is phosphorylated by several protein kinases, including DNA-PK, a nuclear serine/threonine protein kinase that in vitro requires DNA for activity. DNA-PK was recently shown to phosphorylate serines 15 and 37 of human p53 (Lees-Miller et al, 1992. Mol. Cell. Biol., 12, 5041-5049). To prevent phosphorylation at these sites, mutants were constructed that changed the codons for serine 15 or serine 37 to alanine codons. Expression of p53-Ala-37 in stably transformed T98G cells blocked progression of the cells into S phase as well as did the expression of wild-type p53. In contrast, p53-Ala-15 was partially defective in blocking cell cycle progression. Several cell clones transformed with the mutant p53-Ala-15 gene expressed normal levels of p53 mRNA but accumulated little or no detectable p53 protein. However, by using a transient expression system driven by a strong cytomegalovirus promoter, we showed that the inability of p53-Ala-15 to fully block cell cycle progression was not due to inadequate levels of expression or to a failure of the mutant protein to accumulate in the nucleus. These results suggest that phosphorylation of Ser-15 may affect p53 function.
引用
收藏
页码:1519 / 1528
页数:10
相关论文
共 59 条
  • [1] OVERLAP OF THE P53-RESPONSIVE ELEMENT AND CAMP-RESPONSIVE ELEMENT IN THE ENHANCER OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I
    AOYAMA, N
    NAGASE, T
    SAWAZAKI, T
    MIZUGUCHI, G
    NAKAGOSHI, H
    FUJISAWA, JI
    YOSHIDA, M
    ISHII, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (12) : 5403 - 5407
  • [2] SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53
    BAKER, SJ
    MARKOWITZ, S
    FEARON, ER
    WILLSON, JKV
    VOGELSTEIN, B
    [J]. SCIENCE, 1990, 249 (4971) : 912 - 915
  • [3] PREPARATION AND SPECIFICITY OF ANTIBODY TO THYROTROPIN RELEASING HORMONE
    BASSIRI, RM
    UTIGER, RD
    [J]. ENDOCRINOLOGY, 1972, 90 (03) : 722 - &
  • [4] THE HUMAN DNA-ACTIVATED PROTEIN-KINASE PHOSPHORYLATES SIMIAN VIRUS-40 T-ANTIGEN AT AMINO-TERMINAL AND CARBOXY-TERMINAL SITES
    CHEN, YR
    LEESMILLER, SP
    TEGTMEYER, P
    ANDERSON, CW
    [J]. JOURNAL OF VIROLOGY, 1991, 65 (10) : 5131 - 5140
  • [5] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [6] DEGRADATION OF NUCLEAR ONCOPROTEINS BY THE UBIQUITIN SYSTEM INVITRO
    CIECHANOVER, A
    DIGIUSEPPE, JA
    BERCOVICH, B
    ORIAN, A
    RICHTER, JD
    SCHWARTZ, AL
    BRODEUR, GM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (01) : 139 - 143
  • [7] P53 FUNCTIONS AS A CELL-CYCLE CONTROL PROTEIN IN OSTEOSARCOMAS
    DILLER, L
    KASSEL, J
    NELSON, CE
    GRYKA, MA
    LITWAK, G
    GEBHARDT, M
    BRESSAC, B
    OZTURK, M
    BAKER, SJ
    VOGELSTEIN, B
    FRIEND, SH
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (11) : 5772 - 5781
  • [8] WILD-TYPE P53 ACTIVATES TRANSCRIPTION INVITRO
    FARMER, G
    BARGONETTI, J
    ZHU, H
    FRIEDMAN, P
    PRYWES, R
    PRIVES, C
    [J]. NATURE, 1992, 358 (6381) : 83 - 86
  • [9] PRESENCE OF A POTENT TRANSCRIPTION ACTIVATING SEQUENCE IN THE P53 PROTEIN
    FIELDS, S
    JANG, SK
    [J]. SCIENCE, 1990, 249 (4972) : 1046 - 1049
  • [10] FLOTOW H, 1989, J BIOL CHEM, V264, P9126